Table 2.
Neuromodulator | Function | Count | DE | Up | Down |
---|---|---|---|---|---|
5-HT | 5-HT receptor | 17 | 4 | 4 | 0 |
5-HT | 5-HT transporter | 3 | 1 | 1 | 0 |
Acetylcholine | ACH receptor | 35 | 13 | 13 | 0 |
Acetylcholine | ACH transporter | 3 | 2 | 2 | 0 |
Angiotensin | Angiotensin | 16 | 7 | 1 | 6 |
AST | AST | 5 | 4 | 4 | 0 |
AST | AST receptor | 2 | 0 | 0 | 0 |
Callisulfakinin | Callisulfakinin | 1 | 0 | 0 | 0 |
CCAP | CCAP | 1 | 1 | 1 | 0 |
CCAP | CCAP receptor | 2 | 1 | 1 | 0 |
Dopamine | Conversion of dopamine to noradrenaline | 2 | 2 | 2 | 0 |
Dopamine | Dopamine receptor | 6 | 3 | 3 | 0 |
Dopamine | Dopamine transporter | 2 | 0 | 0 | 0 |
FLRFamide | FLRFamide | 3 | 1 | 1 | 0 |
FMRFamide | FMRFamide receptor | 7 | 1 | 1 | 0 |
FMRFamide | FMRFamide-related neuropeptide | 5 | 2 | 2 | 0 |
GABA | GABA receptor | 22 | 4 | 0 | 4 |
GABA | GABA transporter | 12 | 10 | 7 | 3 |
Glutamate | Excitatory amino acid transporter | 11 | 5 | 5 | 0 |
Glutamate | Glutamate receptor | 126 | 52 | 37 | 15 |
Glutamate | Glutamate transporter | 11 | 6 | 6 | 0 |
HCNP | HCNP | 1 | 1 | 1 | 0 |
Myomodulin | Myomodulin | 1 | 1 | 0 | 1 |
NO | Nitric-oxide (NO) synthesis regulation | 29 | 11 | 5 | 6 |
Octopamine | Octopamine receptor | 5 | 0 | 0 | 0 |
Orcokinin | Orcokinin | 5 | 2 | 2 | 0 |
Prohormone-1 | Brain peptide SYWKQCAFNAVSCF-amide | 1 | 1 | 1 | 0 |
RPCH | RPCH | 1 | 1 | 1 | 0 |
SIFamide | SIFamide receptor | 1 | 0 | 0 | 0 |
Substance K | Substance-K receptor | 1 | 0 | 0 | 0 |
Tachykinin | Tachykinin | 1 | 1 | 1 | 0 |
Tachykinin | Tachykinin receptor | 5 | 3 | 3 | 0 |
Transcripts manually curated into functional categories by their annotations. Count is the number of transcripts mapping to a function; DE indicates the number of transcripts differentially expressed in nervous system tissues compared to muscle tissues (adj p < 0.05); up and down signify the number of DE transcripts upregulated (positive log2fold change) or downregulated (negative log2fold change), respectively